| Released | Contributor | Author | Title | Pages | Price |
| 4-Dec-2009 | New Constructs, LLC |
N/A
| LSR: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 3-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 3-Dec-2009 | Jefferson Research |
N/A
| Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of LIFE SCIENCES RESEARCH INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 3 |
$20 |
| 3-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Consulting Industry Market Research and Competitive Analysis 2009 | 408 |
$299 |
| 3-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Consulting Industry Trends, Statistics & Analysis 2009 (Summary) | 29 |
$199 |
| 3-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 |
$199 |
| 3-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 |
$299 |
| 30-Nov-2009 | Reuters Investment Profile |
N/A
| Life Sciences Research Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 27-Nov-2009 | Pechala's Reports | Frantisek Pechala | LIFE SCIENCES RESEARCH INC (LSR=US) 12-months forecast | 1 |
$15 |
| 27-Nov-2009 | Pechala's Reports | Lubomir Pechala | LIFE SCIENCES RESEARCH INC (LSR=US) 2-weeks forecast | 1 |
$10 |
0.22% Nasdaq 
Research Reports
